FunPep Company Limited Logo

FunPep Company Limited

Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.

4881 | T

Overview

Corporate Details

ISIN(s):
JP3802640007
LEI:
Country:
Japan
Address:
茨木市彩都あさぎ七丁目7−15
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

FunPep Company Limited is a clinical-stage biotechnology company that originated as a spin-out from Osaka University. The company specializes in the research and development of therapeutics based on its proprietary functional peptide and antibody-inducing peptide platform technologies. Its core business is creating novel peptide-based pharmaceutical products. FunPep's development pipeline includes candidates for various indications, such as an allergy vaccine and the functional peptide SR-0379 for intractable ulcers, which has advanced to late-stage clinical trials. The company's business scope also extends to the development of functional cosmetics and medical devices, leveraging the diverse applications of its core peptide technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:30
Report Publication Announcement
確認書
Japanese 8.4 KB
2025-08-14 08:30
Interim Report
半期報告書-第13期(2025/01/01-2025/12/31)
Japanese 278.9 KB
2025-04-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2025-03-28 08:16
Registration Form
確認書
Japanese 8.5 KB
2025-03-28 08:15
Annual Report
有価証券報告書-第12期(2024/01/01-2024/12/31)
Japanese 1.6 MB
2025-03-28 08:15
Governance Information
内部統制報告書-第12期(2024/01/01-2024/12/31)
Japanese 23.6 KB
2025-02-21 07:30
Registration Form
有価証券届出書(組込方式)
Japanese 447.3 KB
2024-08-08 09:01
Report Publication Announcement
確認書
Japanese 8.4 KB
2024-08-08 09:00
Interim Report
半期報告書-第12期(2024/01/01-2024/12/31)
Japanese 283.1 KB
2024-08-08 03:00
Major Shareholding Notification
臨時報告書
Japanese 21.3 KB
2024-07-05 08:05
Registration Form
有価証券届出書(組込方式)
Japanese 391.3 KB
2024-05-13 08:00
Quarterly Report
確認書
Japanese 8.4 KB
2024-05-13 08:00
Quarterly Report
四半期報告書-第12期第1四半期(2024/01/01-2024/03/31)
Japanese 238.2 KB
2024-04-01 08:05
Post-Annual General Meeting Information
臨時報告書
Japanese 27.7 KB
2024-03-28 07:15
Registration Form
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all FunPep Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FunPep Company Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FunPep Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.